Advertisement

International Ophthalmology

, Volume 38, Issue 3, pp 1211–1217 | Cite as

Endothelial cell changes after photorefractive keratectomy with graded usage of mitomycin C

  • Hamid Gharaee
  • Siamak Zarei-Ghanavati
  • Reza Alizadeh
  • Mojtaba Abrishami
Original Paper
  • 102 Downloads

Abstract

Purpose

To compare differences in the endothelial cells before and after photorefractive keratectomy (PRK) for myopia with refractive error graded mitomycin C (MMC) application.

Methods

In a prospective randomized clinical trial, forty-eight myopic patients referred to Khatam-al-Anbia Eye Hospital, Mashhad, Iran, for PRK. Patients were treated with PRK by a Bausch and Lomb Technolas 217z excimer laser (Bausch and Lomb, Rochester, NY). MMC was applied after PRK 5 s for each diopter of spherical equivalent myopic refractive error corrected. The manifest refraction, visual acuity, MMC treatment length, corneal pachymetry and specular microscopy were evaluated preoperatively and at 1 and 6 months postoperatively.

Results

A total of 48 cases (96 eyes, 68.75% female) were treated, with a mean age of 26.70 ± 4.89 years (range, 18–34 years). Postoperative cell density, cell size and polymegathism did not significantly change. On the other hand, standard deviation (SD) of cell size (P = 0.008), pleomorphism (P = 0.003) and coefficient of variation (CV) (P = 0.016) were significantly increased. None of these parameters was related to the length of MMC application. Corneal thickness decreased significantly after the operation but it increased 6 months postoperatively compared with the first month (P < 0.001).

Conclusion

MMC application for PRK in myopia can affect the endothelial cells, but in early follow-ups, it does not affect the cell density or size. Cell size was changed but it was obvious not in mean cell size, but in SD and CV. MMC time below the 30 s was not significant on endothelial cell changes.

Keywords

Endothelial cell Mitomycin Photorefractive keratectomy 

Notes

Acknowledgements

The authors would like to thank Sophie Deng, MD, Ph.D., Associate Professor of Ophthalmology at Jules Stein Eye Institute, for her kind help in revising the manuscript. We also would like to thank Pardis Eghbali, BSc, for her help in PRK procedures, Maryam Kadkhoda, BSc, and Jalil Rahimi, BSc, for their help in optometric tests, Parisa Eghbali, MSc, for her assistance in statistical analysis. It is a pleasure for us to appreciate kindness of Capt. Hossein Goli. This work was part of ophthalmology residency thesis of Dr. Mojtaba Abrishami and was supported by research Grant Number 88708 from office of Vice-Chancellor for Research Affairs of Mashhad University of Medical Sciences.

Funding

No funding was received for this research.

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest.

Ethical approval

The research followed the tenets of the Declaration of Helsinki and was approved by the Mashhad University of Medical Sciences Research Ethics Committee.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Hata T, Hoshi T, Kanamori K, Matsumae A, Sano Y, Shima T et al (1956) Mitomycin, a new antibiotic from streptomyces. I. J Antibiot (Tokyo) 9:141–146Google Scholar
  2. 2.
    Mandour SS, Farahat HG, Mohamed HM (2011) Preoperative subpterygial mitomycin C injection versus limbal conjunctival autograft transplantation for prevention of pterygium recurrence. J Ocul Pharmacol Ther 27(5):481–485CrossRefPubMedGoogle Scholar
  3. 3.
    Enock ME, Omoti AE, Dawodu OA et al (2010) Effectiveness of intra-operative mitomycin-C in reducing the recurrence of pterygium in Irrua, Nigeria. Niger Postgrad Med J 17(1):55–59PubMedGoogle Scholar
  4. 4.
    Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark WJ (1991) Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 109:1141–1146CrossRefPubMedGoogle Scholar
  5. 5.
    Schipper I, Suppelt C, Gebbers JO (1997) Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye (Lond) 11:649–655CrossRefGoogle Scholar
  6. 6.
    Wan Norliza WM, Raihan IS, Azwa JA et al (2006) Scleral melting 16 years after pterygium excision with topical Mitomycin C adjuvant therapy. Cont Lens Anterior Eye 29(4):165–167CrossRefPubMedGoogle Scholar
  7. 7.
    Karalezli A, Kucukerdonmez C, Borazan M et al (2010) Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation. Orbit 29(2):88–90CrossRefPubMedGoogle Scholar
  8. 8.
    Peponis V, Rosenberg P, Chalkiadakis SE et al (2009) Fungal scleral keratitis and endophthalmitis following pterygium excision. Eur J Ophthalmol 19(3):478–480CrossRefPubMedGoogle Scholar
  9. 9.
    Jain V, Shome D, Natarajan S et al (2008) Surgically induced necrotizing scleritis after pterygium surgery with conjunctival autograft. Cornea 27(6):720–721CrossRefPubMedGoogle Scholar
  10. 10.
    Tsai YY, Lin JM, Shy JD (2002) Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea 21(2):227–229CrossRefPubMedGoogle Scholar
  11. 11.
    Bayer A, Mutiu FM, Sobaci G (2001) Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis. Ophthalmic Surg Lasers 32(6):490–493PubMedGoogle Scholar
  12. 12.
    Altan T, Temel A, Bavbek T et al (1994) Hypotonic maculopathy after trabeculectomy with postoperative use of 5-fluorouracil. Ophthalmologica 208(6):318–320CrossRefPubMedGoogle Scholar
  13. 13.
    Costa VP, Wilson RP, Moster MR et al (1993) Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surg 24(6):389–394PubMedGoogle Scholar
  14. 14.
    Suñer IJ, Greenfield DS, Miller MP et al (1997) Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology 104(2):207–214 [Discussion 214–215] CrossRefPubMedGoogle Scholar
  15. 15.
    Morales AJ, Zadok D, Mora-Retana R, Martínez-Gama E, Robledo NE, Chayet AS (2006) Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol 142:400–404CrossRefPubMedGoogle Scholar
  16. 16.
    Nassiri N, Farahangiz S, Rahnavardi M, Rahmani L, Nassiri N (2008) Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg 34:902–908CrossRefPubMedGoogle Scholar
  17. 17.
    McDermott ML, Wang J, Shin DH (1994) Mitomycin and the human corneal endothelium. Arch Ophthalmol 112:533–537CrossRefPubMedGoogle Scholar
  18. 18.
    Garweg JG, Wegmann-Burns M, Goldblum D (2006) Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines. Graefes Arch Clin Exp Ophthalmol 244:382–389CrossRefPubMedGoogle Scholar
  19. 19.
    Wu KY, Hong SJ, Huang HT, Lin CP, Chen CW (1999) Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells. J Ocul Pharmacol Ther 15:401–411CrossRefPubMedGoogle Scholar
  20. 20.
    Lee DH, Chung HS, Jeon YC, Boo SD, Yoon YD, Kim JG (2005) Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg 31:2293–2298CrossRefPubMedGoogle Scholar
  21. 21.
    Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G et al (2007) Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg 23:724–727PubMedGoogle Scholar
  22. 22.
    de Benito-Llopis L, Teus MA, Ortega M (2007) Effect of mitomycin-C on the corneal endothelium during excimer laser surface ablation. J Cataract Refract Surg 33:1009–1013CrossRefPubMedGoogle Scholar
  23. 23.
    Diakonis VF, Pallikaris A, Kymionis GD, Markomanolakis MM (2007) Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. Am J Ophthalmol 144:99–103CrossRefPubMedGoogle Scholar
  24. 24.
    Gambato C, Ghirlando A, Moretto E, Busato F, Midena E (2005) Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 112:208–218CrossRefPubMedGoogle Scholar
  25. 25.
    Zhao LQ, Wei RL, Ma XY, Zhu H (2008) Effect of intraoperative mitomycin-C on healthy corneal endothelium after laser-assisted subepithelial keratectomy. J Cataract Refract Surg 34:1715–1719CrossRefPubMedGoogle Scholar
  26. 26.
    Santhiago MR, Netto MV, Wilson SE (2012) Mitomycin C: biological effects and use in refractive surgery. Cornea 31(3):311–321CrossRefPubMedGoogle Scholar
  27. 27.
    Shojaei A, Ramezanzadeh M, Soleyman-Jahi S, Almasi-Nasrabadi M, Rezazadeh P, Eslani M (2013) Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia. J Cataract Refract Surg 39(2):197–203CrossRefPubMedGoogle Scholar
  28. 28.
    Gambato C, Miotto S, Cortese M, Ghirlando A, Lazzarini D, Midena E (2011) Mitomycin C-assisted photorefractive keratectomy in high myopia: a long-term safety study. Cornea 30(6):641–645CrossRefPubMedGoogle Scholar
  29. 29.
    Zare M, Jafarinasab MR, Feizi S, Zamani M (2011) The effect of mitomycin-C on corneal endothelial cells after photorefractive keratectomy. J Ophthalmic Vis Res 6(1):8–12PubMedPubMedCentralGoogle Scholar
  30. 30.
    Nassiri N, Farahangiz S, Rahnavardi M, Rahmani L, Nassiri N (2008) Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg 34(6):902–908CrossRefPubMedGoogle Scholar
  31. 31.
    Morales AJ, Zadok D, Mora-Retana R, Martínez-Gama E, Robledo NE, Chayet AS (2006) Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol 142(3):400–404CrossRefPubMedGoogle Scholar
  32. 32.
    Roh DS, Funderburgh JL (2009) Impact on the corneal endothelium of mitomycin C during photorefractive keratectomy. J Refract Surg 25(10):894–897CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  • Hamid Gharaee
    • 1
  • Siamak Zarei-Ghanavati
    • 1
  • Reza Alizadeh
    • 2
  • Mojtaba Abrishami
    • 3
  1. 1.Eye Research Center Mashhad University of Medical SciencesMashhadIran
  2. 2.Stein Eye Institute, Glaucoma DivisionUniversity of California, Los Angeles (UCLA)Los AngelesUSA
  3. 3.Eye Research Center, Khatam Eye Hospital Mashhad University of Medical SciencesMashhadIran

Personalised recommendations